Zio XT ECG Monitoring System vs KardiaPro
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT if you need extended, continuous cardiac monitoring for up to 14 days with high patient compliance, especially for detecting intermittent or asymptomatic arrhythmias. Its water-resistant, wire-free design allows patients to maintain normal daily activities, and the integrated AI and expert review streamline data analysis for accurate diagnosis.
View Zio XT ECG Monitoring System →Choose KardiaPro if…
Choose KardiaPro if you require a comprehensive remote patient monitoring platform that integrates ECG, blood pressure, and weight data for ongoing management of chronic cardiac conditions. This web-based portal with FDA-cleared AI is ideal for clinicians who need to review trends, triage abnormal readings efficiently, and make informed decisions between appointments.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | KardiaPro |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Cloud-hosted, Web-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemZio XT is a wearable patch that offers continuous monitoring for up to 14 days without external wires, enhancing patient comfort and compliance. While some users report skin irritation, the overall design aims for unobtrusiveness. KardiaPro relies on patient-initiated ECG recordings using KardiaMobile devices, which, while portable, requires active engagement from the patient.
Clinical Value
Zio XT ECG Monitoring SystemZio XT has demonstrated a higher diagnostic yield and faster time to clinical diagnosis compared to other ambulatory cardiac monitors, with studies showing a lower likelihood of retesting and reduced acute care utilization. KardiaPro, while valuable for remote monitoring and arrhythmia detection, is often used in conjunction with KardiaMobile devices, and studies highlight its utility in managing conditions like atrial fibrillation.
Pricing & Value
TieBoth tools require contacting the company for specific pricing, indicating a lack of upfront transparency. Both are reimbursable using existing CPT codes, and both companies offer programs or assistance for patient out-of-pocket expenses.
Enterprise Readiness
KardiaProKardiaPro offers a comprehensive web-based portal for healthcare professionals to manage and review various patient data (ECG, BP, weight), with customizable inboxes and automated reports, indicating a more robust platform for enterprise-level patient management. Zio XT focuses primarily on ECG monitoring and data analysis, with its cloud-based platform (ZEUS) for storage and reporting.
Innovation
Zio XT ECG Monitoring SystemZio XT utilizes a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis and offers continuous monitoring for an extended period with a water-resistant, wire-free biosensor. KardiaPro's innovation lies in its comprehensive remote monitoring platform and integration with various KardiaMobile devices, including a 6-lead personal ECG.
Support & Docs
TieBoth companies offer HIPAA-compliant and FDA-cleared solutions, suggesting a commitment to regulatory standards. However, specific details regarding the breadth and accessibility of support resources and documentation for healthcare providers are not extensively detailed for either product in the provided information or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | KardiaPro |
|---|---|---|
| Name | Zio XT ECG Monitoring System | KardiaPro |
| Company | iRhythm Technologies | AliveCor |
| Description | A wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. | A comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. It provides a secure platform to manage and review data between appointments, making it easy for healthcare professionals to analyze trends and make informed clinical decisions for improved patient care. |
| Monitoring Duration | Up to 14 days of continuous cardiac monitoring. | Not specified |
| Data Monitored | Single-lead ECG data. | ECG, blood pressure, and weight data. |
| Key Features | Wearable single-lead ECG biosensor (Zio biosensor), continuous ambulatory cardiac monitoring for up to 14 days, water-resistant design, no external leads or wires, proprietary FDA-cleared deep-learned AI algorithm, cloud-based software platform (ZEUS), patient-activated button for symptomatic event logging, high patient compliance (up to 99%) and satisfaction. | Comprehensive web-based portal for remote monitoring, ECG, blood pressure, and weight data management, FDA-cleared AI for arrhythmia detection, customizable ECG inbox for efficient data review, automated summary reports and trend visualization, seamless integration with KardiaMobile and KardiaMobile 6L devices, integration with KardiaStation for point-of-care solutions, HIPAA-compliant and SOC-2 certified data handling. |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or KardiaPro
Backers
Who funded each tool's parent company.